VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3347
ETF rank
ยฃ16.42 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ21.06
Share price
-0.65%
Change (1 day)
31.49%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of September 2026: 0.35%